Skip to main content

Month: June 2020

L’OREAL : Déclaration du nombre total de droits de vote et du nombre d’actions composant le capital au 31 mai 2020

Société anonyme au capital de 111 855 722,20 eurosSiège social : 14, rue Royale, 75008 Paris632 012 100 R.C.S. ParisLegal Entity Identifyer : 529900JI1GG6F7RKVI53Déclaration du nombre total de droits de vote et du nombre d’actions composant le capital au 31 mai 2020Conformément aux articles L.233-8 II du Code de commerce et 223-16 du Règlement Général de l’Autorité des Marchés Financiers.(*) en application de l’article 223-11 du Règlement Général de l’Autorité des Marchés FinanciersÀ propos de L’Oréal

Continue reading

NIO Inc. Announces Pricing of Offering of 72,000,000 American Depositary Shares

SHANGHAI, China, June 11, 2020 (GLOBE NEWSWIRE) — NIO Inc. (NYSE: NIO) (“NIO” or the “Company”), a pioneer in China’s premium smart electric vehicle market, today announced the pricing of the offering of 72,000,000 American depositary shares (the “ADSs”), each representing one Class A ordinary share of the Company (the “ADS Offering”), at a price of US$5.95 per ADS. The Company will grant the underwriters in the ADS Offering a 30-day option to purchase up to an additional 10,800,000 ADSs.Morgan Stanley & Co. LLC, Credit Suisse Securities (USA) LLC and China International Capital Corporation Hong Kong Securities Limited are acting as the joint book-running managers for the ADS Offering.The ADSs are offered under the Company’s shelf registration statement on Form F-3 (the “Form F-3”) which was filed with the Securities...

Continue reading

FTI Consulting Expands Technology Segment in EMEA with the Appointment of New Leaders

LONDON, June 11, 2020 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today announced the appointment of three Senior Managing Directors and a Managing Director to its Technology segment in Europe, the Middle East and Africa (“EMEA”). The addition of Jonathan Chan, Renato Fazzone, Richard Palmer and Grainne Bryan will bolster the firm’s global reach and expert-driven solutions to support clients with their legal, regulatory and data-related challenges.“We continue to invest in new talent and innovative solutions to best serve our clients globally,” said Paul Walker, a Senior Managing Director and EMEA Head of Technology at FTI Consulting. “These new senior leaders strengthen our breadth of expertise in e-discovery and data analysis and bring FTI Technology into new jurisdictions. Their addition to our team is reflective of our...

Continue reading

Share Buyback Transaction Details June 4 – 10, 2020

Share Buyback Transaction Details June 4 – 10, 2020June 11, 2020 – Wolters Kluwer today reports that it has repurchased 58,710 its own ordinary shares in the period from June 4, 2020, up to and including June 10, 2020, for €4.0 million and at an average share price of €67.59.These repurchases are part of the share buyback program announced on February 26, 2020, under which we intend to repurchase shares for up to €350 million during 2020.The cumulative amounts repurchased to date under this program are as follows:Share Buyback 2020For the period starting May 7, 2020, up to and including August 3, 2020, we have engaged a third party to execute €50 million of buybacks on our behalf, within the limits of relevant laws and regulations (in particular Regulation (EU) 596/2014) and the company’s Articles of Association.Repurchased shares...

Continue reading

Philips Lumify handheld ultrasound solution launched in Japan to enable powerful diagnostics at the bedside

June 11, 2020Philips’ Lumify handheld diagnostic ultrasound solution with telehealth capabilities meets the demands of Japan’s changing healthcare demographicsOptional Lumify with Reacts capability adds tele-ultrasound to enable healthcare professionals to remotely collaborate and exchange expert advice during diagnosisSolution also recognized for benefit to humankind by IEEE SpectrumAmsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that its Lumify with Reacts handheld tele-ultrasound solution is now commercially available in Japan. Philips has received clearance from Japan’s healthcare authority to introduce the ultrasound solution for compatible handheld devices [1] in the world’s third largest healthcare market after the US and China. Launched in Japan with a novel...

Continue reading

Nexans:

Press release, Paris, France 11th June 2020Nexans secures French State backed €280 million Term Loan facilityParis La Défense, June 11th, 2020 – Nexans announced today the execution of a French State backed €280 million term loan (“PGE”) (“the Facility”), issued by a pool of French banks with a twelve-month maturity and an extension option, up to five years, exercisable by Nexans. The French state is guaranteeing the Facility at 80%.As of March 31st, 2020, and prior to securing the Facility, Nexans liquidity position already stood at sound 1.0 billion euros, including a 600 million euros undrawn revolving credit facility. Early April 2020, the Group has drawn down 200 million euros from the revolving credit facility to repay commercial papers at maturity. Nexans has sufficient liquidity for its operations and foreseen...

Continue reading

ABT in partnership with Canadian skincare products developer

Aqua Bio Technology (ABT) has entered into a strategic partnership with DCP Dermoscience of Canada. The cooperation includes worldwide distribution rights for several DCP skincare products and joint development of new products.DCP Dermoscience is a Quebec based cosmetics company developing and manufacturing natural skincare products. The company has developed and manufactured products for several renowned brands, such as L’Oreal, Johnson & Johnson and Gillette. Like ABT, DCP focuses on skin care products of marine and botanic origin.The business development and distribution agreement enables two attractive opportunities: ABT has attained distribution rights for a number of DCP skincare products worldwide, excl. Canada. ABT has during the last two years developed a distribution network for skincare products covering three continents....

Continue reading

ABT i partnerskap med canadisk produsent av hudpleieprodukter

Aqua Bio Technology (ABT) har inngått et strategisk partnerskap med det canadiske selskapet DCP Dermoscience. Samarbeidet omfatter verdensomfattende distribusjonsrettigheter for flere av DCPs hudpleieprodukter og felles utvikling av nye produkter.DCP Dermoscience er et kosmetikkselskap i den canadiske Quebec-provinsen. Selskapet utvikler og produserer naturlige hudpleieprodukter. DCP har utviklet og produsert produkter for en rekke kjente varemerker som L’Oreal, Johnson & Johnson og Gillette. På samme måte som ABT, fokuserer også DCP på hudpleieprodukter av marint og botanisk opphav.Avtalen om forretningsutvikling og distribusjon innebærer to attraktive forretningsmuligheter: ABT har fått distribusjonsrettighetene for flere av DCPs hudpleieprodukter for hele verden unntatt Canada. ABT har de siste to årene bygget opp et distribusjonsnettverk...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.